JRP
DNA icon

Jasper Ridge Partners’s Ginkgo Bioworks DNA Stock Holding History

Jasper Ridge Partners’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,673
Closed -$49.1K – 146
2024
Q2 		$49.1K Hold
3,673
– – ﹤0.01% 143
2024
Q1 		$170K Hold
3,673
– – 0.01% 137
2023
Q4 		$248K Hold
3,673
– – 0.01% 125
2023
Q3 		$266K Hold
3,673
– – 0.01% 115
2023
Q2 		$273K Hold
3,673
– – 0.01% 118
2023
Q1 		$195K Hold
3,673
– – 0.01% 133
2022
Q4 		$248K Hold
3,673
– – 0.01% 115
2022
Q3 		$458K Hold
3,673
– – 0.03% 101
2022
Q2 		$350K Hold
3,673
– – 0.02% 113
2022
Q1 		$592K Buy
+3,673
New +$715K 0.03% 104

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jasper Ridge Partners's DNA Position: Q3 2024 in Review

Jasper Ridge Partners sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 3,673 shares — an estimated $49.1K sold.

Jasper Ridge Partners first reported a position in DNA in Q1 2022 and held it in 10 quarters. The position peaked at $592K in Q1 2022. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Jasper Ridge Partners reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Jasper Ridge Partners sold 3,673 Ginkgo Bioworks shares in Q3 2024, an estimated $49.1K.
  • Jasper Ridge Partners first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 10 quarters.
  • Jasper Ridge Partners's Ginkgo Bioworks position peaked at $592K in Q1 2022.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Jasper Ridge Partners's 13F filing for Q3 2024, filed 14 Nov 2024.